Literature DB >> 27003447

No evidence that HPV vaccination leads to sexual risk compensation.

Bo T Hansen1.   

Abstract

Uptake of the HPV vaccine has been lower than the uptake of most other childhood vaccines offered in public programs. Since the HPV vaccine protects against a sexually transmitted virus, one barrier to uptake specific to the HPV vaccine may be the concern that vaccination may encourage risky sexual behaviour. Unanimous findings from recent studies show that HPV vaccination does not lead to sexual risk compensation, which is an important message to parents, clinicians and other decision-makers regarding HPV vaccination. Some issues remain to be investigated, like HPV vaccination and sexual risk compensation among boys.

Entities:  

Keywords:  behavioral adaptation; cervical cancer; human papillomavirus; risk compensation; sexual disinhibition; sexual health; STI

Mesh:

Substances:

Year:  2016        PMID: 27003447      PMCID: PMC4964744          DOI: 10.1080/21645515.2016.1158367

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  24 in total

1.  Will risk compensation accompany pre-exposure prophylaxis for HIV?

Authors:  Jill Blumenthal; Richard H Haubrich
Journal:  Virtual Mentor       Date:  2014-11-01

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  An investigation of behavioural adaptation to airbags and antilock brakes among taxi drivers.

Authors:  F Sagberg; S Fosser; I A Saetermo
Journal:  Accid Anal Prev       Date:  1997-05

4.  Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations.

Authors:  S D Pinkerton
Journal:  Risk Anal       Date:  2001-08       Impact factor: 4.000

5.  Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya.

Authors:  Nelli Westercamp; Kawango Agot; Walter Jaoko; Robert C Bailey
Journal:  AIDS Behav       Date:  2014-09

6.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

7.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

Authors:  Kevin A Ault
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

8.  Differences in risky sexual behaviors and HIV prevalence of circumcised and uncircumcised men in Uganda: evidence from a 2011 cross-sectional national survey.

Authors:  Simon P S Kibira; Elizabeth Nansubuga; Nazarius M Tumwesigye; Lynn M Atuyambe; Fredrick Makumbi
Journal:  Reprod Health       Date:  2014-03-24       Impact factor: 3.223

9.  Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008).

Authors:  Shona Hilton; Kate Hunt; Mairi Langan; Helen Bedford; Mark Petticrew
Journal:  Soc Sci Med       Date:  2010-01-11       Impact factor: 4.634

10.  Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Authors:  Lisen Arnheim-Dahlström; Björn Pasternak; Henrik Svanström; Pär Sparén; Anders Hviid
Journal:  BMJ       Date:  2013-10-09
View more
  3 in total

1.  Behavioral intention to perform risk compensation behaviors after receiving HPV vaccination among men who have sex with men in China.

Authors:  Terence Wu; Shuyu Qu; Yuan Fang; Mary Ip; Zixin Wang
Journal:  Hum Vaccin Immunother       Date:  2019-06-20       Impact factor: 3.452

2.  Give PrEP a chance: moving on from the "risk compensation" concept.

Authors:  Daniela Rojas Castro; Rosemary M Delabre; Jean-Michel Molina
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

3.  Association between health behaviours and the COVID-19 vaccination: risk compensation among healthcare workers in Taizhou, China.

Authors:  Liang-Xue Sun; Li-Li Chen; Wei-Ying Chen; Mei-Xian Zhang; Meng-Ge Yang; Li-Cai Mo; Jing-Jing Zhu; Tao-Hsin Tung; Fei-Ping Li
Journal:  Hum Vaccin Immunother       Date:  2022-02-17       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.